RCN1 and lung cancer: Specially, in non‐small cell lung cancer (NSCLC), overexpression of RCN1 correlates with poor prognosis and progression12 and the efficacy of platinum‐based adjuvant chemotherapy relates with co‐expression of RCN1 and GST‐π.13